CPT1B, a metabolic molecule, is also an independent risk factor in CN-AML

BACKGROUND: Fatty acid oxidation has been considered as an important energy source for tumorigenesis and development. Several studies have investigated the role of CPT1A, a kind of fatty acid oxidation rate-limiting enzyme, in AML. However, prognostic value and regulatory network of another subtype, CPT1B in AML remains elusive. This study aims to clarify the independent prognostic role of CPT1B in CN-AML based on clinical data and molecular level data (mRNA, miRNA and lncRNA). OBJECTIVE: The aim of this study is to investigate the prognostic value of CPT1B in AML patients. METHODS: First, we analyzed the CPT1B expression in AML cohort via the online database “GEPIA”. Subsequently, miRNA-mRNA and ceRNA networks were constructed to help predict the role of CPT1B in AML. Several molecules which showed the prognostic value and metabolic function of CPT1B were identified. Finally, the expression of CPT1B in our own cohort of 324 CN-AML patients was analyzed to clarify the results. RESULTS: It was found that CPT1B was markedly higher in AML patients compared to normal people and this upregulation was associated with the poor clinical outcome. Several molecules revealed the possible regulatory mechanism of CPT1B in AML. CONCLUSION: CPT1B is a potential prognostic factor and a therapeutic target for AML treatment.

• Publication year

  2020

• Venue

  Cancer Biomarkers

• Publication date

  2020-12-09

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.3233/CBM-210043PMID 36938722
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• lncRNA TTN‐AS1 facilitates proliferation, invasion, and epithelial‐mesenchymal transition of breast cancer cells by regulating miR‐139‐5p/ZEB1 axis

  2020cited by this paper
• Novel Lipid Long Intervening Noncoding RNA, Oligodendrocyte Maturation‐Associated Long Intergenic Noncoding RNA, Regulates the Liver Steatosis Gene Stearoyl‐Coenzyme A Desaturase As an Enhancer RNA

  2019cited by this paper
• The dual functional role of MicroRNA-18a (miR-18a) in cancer development

  2019cited by this paper
• Polymorphisms of a novel long non-coding RNA RP11-108K3.2 with colorectal cancer susceptibility and their effects on its expression

  2019cited by this paper
• Cytoscape stringApp: Network analysis and visualization of proteomics data

  2018cited by this paper
• MALAT1 Promotes the Proliferation and Metastasis of Osteosarcoma Cells By Activating the Rac1/JNK Pathway Via Targeting MiR-509.

  2018cited by this paper
• JAK/STAT3-Regulated Fatty Acid β-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance.

  2018cited by this paper
• miR-339 Promotes Development of Stem Cell Leukemia/Lymphoma Syndrome via Downregulation of the BCL2L11 and BAX Proapoptotic Genes.

  2018cited by this paper
• Bipartite network analysis reveals metabolic gene expression profiles that are highly associated with the clinical outcomes of acute myeloid leukemia

  2017cited by this paper
• The role of p53 in myelodysplastic syndromes and acute myeloid leukemia: molecular aspects and clinical implications

  2017cited by this paper
• The STRING database in 2017: quality-controlled protein–protein association networks, made broadly accessible

  2016cited by this paper
• Prognostic impact of MYH9 expression on patients with acute myeloid leukemia

  2016cited by this paper
• High Expression of CPT1A Predicts Adverse Outcomes: A Potential Therapeutic Target for Acute Myeloid Leukemia

  2016cited by this paper
• Targeting mTOR signaling pathways and related negative feedback loops for the treatment of acute myeloid leukemia

  2015cited by this paper
• Prognostic Value of MicroRNA-182 in Cancers: A Meta-Analysis

  2015cited by this paper
• Targeting the leukemia cell metabolism by the CPT1a inhibition: functional preclinical effects in leukemias.

  2015cited by this paper
• DIANA-miRPath v3.0: deciphering microRNA function with experimental support

  2015cited by this paper
• A distinct glucose metabolism signature of acute myeloid leukemia with prognostic value.

  2014cited by this paper
• cytoHubba: identifying hub objects and sub-networks from complex interactome

  2014cited by this paper
• Cancer metabolism: fatty acid oxidation in the limelight

  2013cited by this paper
• Prognostic significance of 2-hydroxyglutarate levels in acute myeloid leukemia in China

  2013cited by this paper
• Therapeutic targets in cancer cell metabolism and autophagy

  2012cited by this paper
• High expression of lymphoid enhancer-binding factor-1 (LEF1) is a novel favorable prognostic factor in cytogenetically normal acute myeloid leukemia.

  2012cited by this paper
• Therapeutic advances in acute myeloid leukemia.

  2011cited by this paper
• microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia

  2010cited by this paper
• Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study.

  2010cited by this paper
• Cancer cell metabolism: Warburg and beyond.

  2008cited by this paper
• WGCNA: an R package for weighted correlation network analysis

  2008cited by this paper
• GSEA-P: a desktop application for Gene Set Enrichment Analysis

  2007cited by this paper

• A randomized double-blind clinical trial investigating the effects of ellagic acid on glycemic status, liver enzymes, and oxidative stress in patients with non-alcoholic fatty liver disease

  2025cites this paper
• Ribosomal protein control of hematopoietic stem cell transformation through regulation of metabolism

  2025cites this paper
• miR-504 knockout regulates tumor cell proliferation and immune cell infiltration to accelerate oral cancer development.

  2024cites this paper
• The Role of the CPT Family in Cancer: Searching for New Therapeutic Strategies

  2024cites this paper
• High expression of malic enzyme 1 predicts adverse prognosis in patients with cytogenetically normal acute myeloid leukaemia and promotes leukaemogenesis through the IL-6/JAK2/STAT3 pathways

  2024cites this paper
• Ribosomal protein control of hematopoietic stem cell transformation through regulation of metabolism

  2023cites this paper